Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

Genetic influences on cognition in progressive supranuclear palsy.

Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan I.

Mov Disord. 2017 Oct 27. doi: 10.1002/mds.27196. [Epub ahead of print]

PMID:
29076559
2.

What would Dr. James parkinson think today? Mutations in beta-glucocerebrosidase and risk of Parkinson's disease.

Standaert DG.

Mov Disord. 2017 Oct;32(10):1341-1342. doi: 10.1002/mds.27206. Review. No abstract available.

PMID:
29068500
3.

Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease.

Amara AW, Walker HC, Joop A, Cutter G, DeWolfe JL, Harding SM, Standaert DG.

Mov Disord Clin Pract. 2017 Mar-Apr;4(2):183-190. doi: 10.1002/mdc3.12375. Epub 2016 Jun 6.

PMID:
28924578
4.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

PMID:
28887905
5.

Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia.

Zimmerman CN, Eskow Jaunarajs KL, Meringolo M, Rizzo FR, Santoro M, Standaert DG, Pisani A.

Front Syst Neurosci. 2017 Jun 13;11:43. doi: 10.3389/fnsys.2017.00043. eCollection 2017.

6.

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.

Gendelman HE, Zhang Y, Santamaria P, Olson KE, Schutt CR, Bhatti D, Shetty BLD, Lu Y, Estes KA, Standaert DG, Heinrichs-Graham E, Larson L, Meza JL, Follett M, Forsberg E, Siuzdak G, Wilson TW, Peterson C, Mosley RL.

NPJ Parkinsons Dis. 2017 Mar 23;3:10. doi: 10.1038/s41531-017-0013-5. eCollection 2017.

7.

Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.

Scarduzio M, Zimmerman CN, Jaunarajs KL, Wang Q, Standaert DG, McMahon LL.

Exp Neurol. 2017 Sep;295:162-175. doi: 10.1016/j.expneurol.2017.06.005. Epub 2017 Jun 3.

PMID:
28587876
8.

Dysregulation of BET proteins in levodopa-induced dyskinesia.

Figge DA, Standaert DG.

Neurobiol Dis. 2017 Jun;102:125-132. doi: 10.1016/j.nbd.2017.03.003. Epub 2017 Mar 9.

PMID:
28286180
9.

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE.

Mov Disord. 2017 Mar;32(3):319-324. doi: 10.1002/mds.26913. Epub 2017 Feb 24. Review.

PMID:
28233927
10.

The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease.

Birchall EL, Walker HC, Cutter G, Guthrie S, Joop A, Memon RA, Watts RL, Standaert DG, Amara AW.

Brain Stimul. 2017 May - Jun;10(3):651-656. doi: 10.1016/j.brs.2016.12.014. Epub 2016 Dec 27.

PMID:
28065487
11.

Understanding falls in progressive supranuclear palsy.

Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J; ENGENE PSP study.

Parkinsonism Relat Disord. 2017 Feb;35:75-81. doi: 10.1016/j.parkreldis.2016.12.009. Epub 2016 Dec 15.

PMID:
28007518
12.

Cholinergic regulation of striatal dopamine release: New light in dark basements.

Zimmerman CN, Standaert DG.

Mov Disord. 2016 Dec;31(12):1796. doi: 10.1002/mds.26846. Epub 2016 Nov 7. No abstract available.

PMID:
27943474
13.

Glucocerebrosidase, Parkinson disease, and the "senses and intellect".

Standaert DG, Geldmacher DS.

Ann Neurol. 2016 Nov;80(5):660-661. doi: 10.1002/ana.24808. No abstract available.

PMID:
27779773
14.

CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.

Apetauerova D, Scala SA, Hamill RW, Simon DK, Pathak S, Ruthazer R, Standaert DG, Yacoubian TA.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 2;3(5):e266. doi: 10.1212/NXI.0000000000000266. eCollection 2016 Oct.

15.

SNPing SCNA regulatory elements gives a CRISPR view of genetic susceptibility in Parkinson's disease.

Figge DA, Standaert DG.

Mov Disord. 2016 Oct;31(10):1479. doi: 10.1002/mds.26747. No abstract available.

PMID:
27501414
16.

Dynamic DNA Methylation Regulates Levodopa-Induced Dyskinesia.

Figge DA, Eskow Jaunarajs KL, Standaert DG.

J Neurosci. 2016 Jun 15;36(24):6514-24. doi: 10.1523/JNEUROSCI.0683-16.2016.

17.

Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease.

Fraser KB, Rawlins AB, Clark RG, Alcalay RN, Standaert DG, Liu N; Parkinson's Disease Biomarker Program Consortium, West AB.

Mov Disord. 2016 Oct;31(10):1543-1550. doi: 10.1002/mds.26686.

18.

Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis.

Calabresi P, Standaert DG, Chiasserini D, Parnetti L.

Mov Disord. 2016 Jun;31(6):769-70. doi: 10.1002/mds.26683. No abstract available.

PMID:
27245116
19.

Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.

Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd, Meares GP, Yu H, Yan Z, Harms AS, Li Y, Standaert DG, Benveniste EN.

J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.

20.

How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?

Volpicelli-Daley LA, Kirik D, Stoyka LE, Standaert DG, Harms AS.

J Neurochem. 2016 Oct;139 Suppl 1:131-155. doi: 10.1111/jnc.13627. Epub 2016 May 4. Review.

Supplemental Content

Loading ...
Support Center